[1] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组,国家皮肤与免疫疾病临床医学研究中心.中国带状疱疹诊疗专家共识(2022版)[J].中华皮肤科杂志,2022,55 ( 12) : 1033-1040.
[2] KATZ J,MELZACK R.Measurement of pain[J].Surg Clin North Am,1999,79( 2) :231-252.
[3] BABAMAHMOODI F,ALIKHANI A,AHANGARKANI F,et al. Clinical manifestations of herpes zoster,its comorbidities,and its complications in north of Iran from 2007 to 2013[J].Neurol Res Int,2015,2015: 896098.
[4] 出自:中国带状疱疹诊疗专家共识(2022版)
[5] GERSHON AA,GERSHON MD,BREUER J,et al. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster[J]. J Clin Virol,2010,48 ( Suppl 1) : S2-7。
[6] SCHMADER KE,LEVIN MJ,GNANN JR JW,et al. Efficacy, safety,and tolerability of herpes zoster vaccine in persons aged 50-59 years[J]. Clin Infect Dis,2012,54( 7) : 922-928.
[7] 熊梅,骆志成.带状疱疹流行病学研究进展[J]. 实用临床医药杂志,2022,26( 7) : 144-148.
[8] LU L,SUO L,LI J,et al. A retrospective survey on herpes zoster disease burden and characteristics in Beijing,China[J]. Hum Vaccin Immunother,2018,14( 11) : 2632-2635.
[9] HARPAZ R,ORTEGA-SANCHEZ IR,SEWARD JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices ( ACIP) [J]. MMWR Recomm Rep, 2008,57( RR-5) : 1-30+34
[10] CHEN S-Y,SUAYA JA,LI Q,et al. Incidence of herpes zoster in patients with altered immune function[J]. Infection,2014,42 ( 2) : 325-334.
[11] KIM YJ,LEE CN,LEE MS,et al.Recurrence rate of herpes zoster and its risk factors: a population-based cohort study[J]. J Korean Med Sci,2018,34( 2) : e1.
[12] YAWN BP,GILDEN D. The global epidemiology of herpes zoster [J]. Neurology,2013,81( 10) : 928-930
[13] TSENG HF,BRUXVOORT K,ACKERSON B,et al. The epidemiology of herpes zoster in immunocompetent,unvaccinated adults ≥50 years old: incidence,complications,hospitalization, mortality,and recurrence[J]. J Infect Dis,2020,222( 5) : 798- 806.
[14] NAKAMURA Y,MIYAGAWA F,OKAZAKI A,et al. Shozu Herpes Zoster Study Group. Clinical and immunologic features of recurrent herpes zoster ( HZ) [J]. J Am Acad Dermatol,2016, 75( 5) : 950-956,e1.
[15]Schmader K,Oxman MN,Levin MJ,et al.Persistence of zoster vaccine efficacy.In:Programs and Abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Infectious Disease Society of America Meeting.Alexandria,VA;2008.1310-1322,2009.